Valuation: Cellnovo

Market Cap 24.36L 21.03L 19.75L 17.98L 33.77L 23Cr 34.27L 2.32Cr 90.65L 12Cr 91.44L 89.45L 39Cr P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 1.25Cr 1.08Cr 1.01Cr 91.96L 1.73Cr 119.09Cr 1.75Cr 12Cr 4.64Cr 60Cr 4.68Cr 4.58Cr 198.51Cr EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26.79L
+0.75%+14.49%-26.59%+33.89% 1.8TCr
-2.06%-13.39% - - 1.28TCr
-4.25%-2.81%-27.55%-43.45% 914.94Cr
-5.72%-7.33%-3.92%+101.11% 809.69Cr
+4.04%-14.25%-43.49%+185.76% 407.93Cr
-1.66%-2.82%-42.22%-15.34% 245.58Cr
-0.82%-3.44%-35.05%-34.23% 191.83Cr
-1.72%+5.02%+33.60%+88.29% 167.88Cr
-1.03%+1.95%+9.87%+67.39% 147.4Cr
Average -0.80%-1.51%-16.92%+47.93% 596.6Cr
Weighted average by Cap. -0.85%+0.03%-22.20%+41.25%

Financials

2018 2019 *
Net sales 33.22L 28.68L 26.93L 24.52L 46.06L 32Cr 46.74L 3.16Cr 1.24Cr 16Cr 1.25Cr 1.22Cr 53Cr -
Net income -1.59Cr -1.38Cr -1.29Cr -1.18Cr -2.21Cr -152.36Cr -2.24Cr -15Cr -5.93Cr -76Cr -5.98Cr -5.85Cr -253.98Cr -
Net Debt 1Cr 86.54L 81.25L 73.98L 1.39Cr 96Cr 1.41Cr 9.53Cr 3.73Cr 48Cr 3.76Cr 3.68Cr 159.7Cr -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock